share

Dabigatran Impurity J CAS NO 211915-00-3


Unit Price:

CAS No.:211915-00-3

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Dabigatran Impurity J is a high-purity reference standard critical for the analytical profiling and quality control of the anticoagulant active pharmaceutical ingredient (API) Dabigatran Etexilate. This compound is essential for pharmaceutical manufacturers and analytical laboratories to ensure product safety, efficacy, and regulatory compliance by accurately identifying and quantifying related substances. It is primarily used in research and development, method validation, and stability studies within the pharmaceutical industry.

Application

  • Pharmaceutical Reference Standard: Serves as a certified impurity standard for the identification and quantification of related substances in Dabigatran Etexilate API and finished dosage forms.
  • Analytical Method Development & Validation: Used to develop, optimize, and validate HPLC, UPLC, or LC-MS methods for impurity profiling.
  • Quality Control & Assurance (QC/QA): Critical for routine batch release testing to monitor impurity levels against ICH Q3A(R2) and Q3B(R2) guidelines.
  • Stability Studies: Employed to track the formation of degradation products under various stress conditions (e.g., heat, light, humidity) as per ICH stability protocols.
  • Regulatory Submissions: Provides necessary impurity characterization data for Drug Master Files (DMFs), Investigational New Drug (IND) applications, and New Drug Applications (NDAs).
  • Pharmacopoeial Testing: Supports compliance testing against monographs in pharmacopoeias such as USP, EP, or JP.

Basic Information

Product Name Dabigatran Impurity J
CAS No. 211915-00-3
Molecular Formula C25H25N7O3
Molecular Weight 471.51 g/mol
Synonyms Dabigatran Related Compound J; BIBR 953 Impurity J; Ethyl 3-[(2-{[(4-{N'-[(Hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl](pyridin-2-yl)amino]propanoate; BIBR 1048 Impurity J; Dabigatran Etexilate Impurity J
EINECS Contact for details

Quality Control

Every batch of Dabigatran Impurity J is manufactured under a quality management system and undergoes rigorous analytical testing to ensure identity, purity, and consistency. Our products are characterized using advanced techniques including HPLC, LC-MS, NMR, and IR spectroscopy. A comprehensive Certificate of Analysis (COA) is provided with each shipment, detailing batch-specific results and confirming compliance with in-house specifications suitable for use as a reference standard.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label or COA. This material is hygroscopic (moisture-sensitive) and must be kept in a dry environment. For long-term storage, consider desiccants or inert atmosphere to ensure stability.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0% Any individual unknown impurity ≤ 0.5%
Water Content (KF) ≤ 1.0% w/w
Residue on Ignition ≤ 0.2%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.